30
OBG PRESENTS: EVO / Bioaugmentation for Treatment of Trichloroethene by Biobarrier and Source Injection Approach Christine Fogas (OBG), Michael Kozar, P.G. (OBG), Bella Bakrania (OBG), and Eric Schleicher, P.G. (OBG) Fourth International Symposium on Bioremediation and Sustainable Environmental Technologies May 22-25, 2017, Miami, FL

Revlon EISB Performance Status Update – February 2016€¦ · Long-term solution / low maintenance. No aboveground equipment. 7 Showed TCE degradation, but accumulation ... Total

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

  • OBG PRESENTS:

    EVO / Bioaugmentation for Treatment of Trichloroethene by Biobarrier and Source Injection ApproachChristine Fogas (OBG), Michael Kozar, P.G. (OBG), Bella Bakrania (OBG), and Eric Schleicher, P.G. (OBG)

    Fourth International Symposium on Bioremediation and Sustainable Environmental TechnologiesMay 22-25, 2017, Miami, FL

    http://www.obg.com/

  • Emulsified Vegetable Oil (EVO) and Bioaugmentation for Treatment of Trichloroethene(TCE) by “Biobarrier” and Source Injection Approach

    2

    Background

    Implementation

    Performance Monitoring

  • 3

    Background

  • Site Setting

    4

  • 5

  • 6

    Remedial Objectives

    Remediate source / reduce CVOC mass flux

    Enhance monitored natural attenuation (MNA) downgradient

    Meet New Jersey Groundwater Quality Standards (GWQS) – TCE = 1 ppb; 1,1,1-TCA = 30 ppb

    Key Considerations

    Difficult urban setting

    Treatment needed off-Site

    Long-term solution / low maintenance

    No aboveground equipment

  • 7

    Showed TCE degradation, but accumulation of cDCE with electron donor only (MEAL)

    Showed complete dechlorination to ethene with Dhc addition (KB-1)

    2001 Microcosm

    Conducted at a “hot-spot” in shallow source area 1st Injection = 65 lbs sodium lactate;

    2nd Injection = 600 lbs sodium lactate Bioaugmentation with Dhc

    2003 Field Pilot Study

    Used groundwater from off-site monitoring well where “biobarrier” was planned

    Tested new commercially available electron donors and buffers

    2010 Microcosm

    Enhanced In Situ Bioremediation (EISB) Proof of Concept

  • 8

    Cross Sectional View of Site

  • Biobarrier Segment “B”

    Biobarrier Segment “A”

    Source Area

    9

  • Implementation

    10

  • Overview / Chronology

    11

    • Initial (8) injection wells for EISB pilot test in source area installed June 2003

    • Additional (25) injection wells installed January – March 2014

    • Newman Zone® Standard Emulsified Vegetable Oil (EVO) was selected

    • EVO injection completed over a period of 14 days (September 2014 – October 2014)

    • Bioaugmentation conducted May 2015• TSI-DC Dehalococcoides mccartyii Bioaugmentation Culture®

    supplied by Terra Systems, Inc.

    • Groundwater (GW) sampling / monitoring events conducted:•Baseline (pre-EVO injection): May 2014•Months 1 through 6: November 2014 – April 2015 (pre-bioaugmentation)•Months 7 and beyond: August 2015 – April 2017 (post-bioaugmentation)

    Injection Well

    Install

    EVO Injection

    Bioaugment

    Performance Monitoring

  • Injection WellInstallation

    12

    Off-site barrier well installations

    9-ft high pile of plow snow covering two

    planned drill locations

    Compact Rotosonicdrill rig

  • EVO Injections

    13

    Newman Zone® product tote

    Spill containment Gravity feed setup

    Mixing tanks

    Biobarrier injections

  • 14

    Actual vs. Target EVO Injected in Pounds

    A total of 25,937 lbs of Newman Zone® Standard EVO at 10% concentration (31,438 gallons in solution) was injected in the EISB treatment zones over a period of 14 days

    3,310

    9,981

    12,646

    0

    2,000

    4,000

    6,000

    8,000

    10,000

    12,000

    14,000

    EVO

    Inje

    cted

    (lbs

    )

    SOURCE AREA BARRIER SEGMENT A BARRIER SEGMENT B

    StoichiometricTarget LOW

    (1,620)

    Injection Porosity Target HIGH

    (11,520)

    Injection Porosity Target HIGH

    (11,520)

    Stoichiometric Target LOW

    (3,266)

    Injection Porosity Target HIGH

    (12,370)

    Stoichiometric Target LOW

    (1,814)

  • Bioaugmentation

    15

    TSI-DC Bioaugmentation Culture® contains > 1 x 1011 cells/L of Dehalococcoides mccartyii

    Self-performed bioaugmentation

    Fouling Slowed Progress

    Total of 336 liters of culture injected over a period of 7 days to achieve target concentration of 1 x 107 cells/L in groundwater

  • 16

    Performance Monitoring

  • EVO is fermented to release volatile fatty acids (VFAs), which act as a carbon source for Dhc and other microbes

    17

    EVO InjectionsComplete

    Bioaugmentation

    0

    200

    400

    600

    800

    1000

    1200

    1400

    0

    100

    200

    300

    400

    500

    600

    Conc

    entr

    atio

    n (m

    g/L)

    MW-8C: Volatile Fatty Acids (VFAs) (Source Area - Shallow GW Zone)

    Lactic Acid

    Acetic Acid

    Propionic Acid

    Formic Acid

    Butyric Acid

    Pyruvic Acid

  • EISB Monitoring Wells

    18

  • 19

    Baseline TCE = 3,320 ppb

    April 2017 TCE = 18.4 ppb

    NJ GWQS for TCE = 1 ppb

    EVO InjectionsComplete

    Bioaugmentation

    0

    100

    200

    300

    400

    500

    600

    700

    800

    900

    1,000

    0

    5

    10

    15

    20

    25

    30

    35

    40

    45

    50

    May

    -14

    Jun-

    14Ju

    l-14

    Aug-

    14Se

    p-14

    Oct

    -14

    Nov

    -14

    Dec-

    14Ja

    n-15

    Feb-

    15M

    ar-1

    5Ap

    r-15

    May

    -15

    Jun-

    15Ju

    l-15

    Aug-

    15Se

    p-15

    Oct

    -15

    Nov

    -15

    Dec-

    15Ja

    n-16

    Feb-

    16M

    ar-1

    6Ap

    r-16

    May

    -16

    Jun-

    16Ju

    l-16

    Aug-

    16Se

    p-16

    Oct

    -16

    Nov

    -16

    Dec-

    16Ja

    n-17

    Feb-

    17M

    ar-1

    7Ap

    r-17

    May

    -17

    Tota

    l VFA

    Con

    cent

    ratio

    n (m

    g/L)

    VOC

    Conc

    entr

    atio

    n (µ

    M)

    MW-8C: EISB Source Area - Shallow Overburden Zone

    PCE TCE cDCE VC Ethene + Ethane Total VFA's

  • 20

    Baseline TCE = 9,030 ppb

    NJ GWQS for TCE = 1 ppb

    April 2017 TCE = < 0.26 ppb

    0

    150

    300

    450

    600

    750

    900

    1,050

    1,200

    1,350

    1,500

    0

    10

    20

    30

    40

    50

    60

    70

    80

    90

    100

    May

    -14

    Jun-

    14Ju

    l-14

    Aug-

    14

    Sep-

    14O

    ct-1

    4

    Nov

    -14

    Dec-

    14

    Jan-

    15

    Feb-

    15M

    ar-1

    5

    Apr-

    15M

    ay-1

    5

    Jun-

    15Ju

    l-15

    Aug-

    15

    Sep-

    15O

    ct-1

    5

    Nov

    -15

    Dec-

    15

    Jan-

    16

    Feb-

    16M

    ar-1

    6

    Apr-

    16M

    ay-1

    6

    Jun-

    16Ju

    l-16

    Aug-

    16

    Sep-

    16O

    ct-1

    6

    Nov

    -16

    Dec-

    16

    Jan-

    17

    Feb-

    17M

    ar-1

    7

    Apr-

    17M

    ay-1

    7

    Tota

    l VFA

    Con

    cent

    ratio

    n (m

    g/L)

    VOC

    Conc

    entr

    atio

    n (µ

    M)

    MW-21: EISB Biobarrier - Deep Till Zone

    PCE TCE cDCE VC Ethene + Ethane Total VFA's

  • 21

    Baseline TCE = 3,200 ppb

    NJ GWQS for TCE = 1 ppb

    April 2017 TCE = 2.1 ppb

    EVO InjectionsComplete

    Bioaugmentation

    0

    150

    300

    450

    600

    750

    900

    1,050

    1,200

    1,350

    1,500

    0

    5

    10

    15

    20

    25

    30

    35

    40

    45

    50

    May

    -14

    Jun-

    14Ju

    l-14

    Aug-

    14Se

    p-14

    Oct

    -14

    Nov

    -14

    Dec-

    14Ja

    n-15

    Feb-

    15M

    ar-1

    5Ap

    r-15

    May

    -15

    Jun-

    15Ju

    l-15

    Aug-

    15Se

    p-15

    Oct

    -15

    Nov

    -15

    Dec-

    15Ja

    n-16

    Feb-

    16M

    ar-1

    6Ap

    r-16

    May

    -16

    Jun-

    16Ju

    l-16

    Aug-

    16Se

    p-16

    Oct

    -16

    Nov

    -16

    Dec-

    16Ja

    n-17

    Feb-

    17M

    ar-1

    7Ap

    r-17

    May

    -17

    Tota

    l VFA

    Con

    cent

    ratio

    n (m

    g/L)

    VOC

    Conc

    entr

    atio

    n (µ

    M)

    MW-22: EISB Biobarrier - Deep Till Zone

    PCE TCE cDCE VC Ethene + Ethane Total VFA's

  • 22

    TCE Concentrations (ppb)Historic Range* April 2017 Results

    Source Area Monitoring WellsMW-8 (shallow overburden)+ 110 – 3,300 < 0.26MW-8B (shallow overburden) 54 - 760 5,270MW-8C (shallow overburden) 130 - 6,100 18.4MW-8D (shallow overburden) 42 - 17,000 < 0.26MW-20 (intermediate till) 400 - 25,000 580MW-18 (deep till) 130 - 340 148Barrier Segment “B” Monitoring WellMW-21 (deep till) 5,500 - 16,000 < 0.26Barrier Segment “A” Monitoring WellMW-22 (deep till) 580 - 9,000 2.1Notes:NJ GWQS for TCE = 1 ppb, cDCE = 70 ppbJ = estimated value* Excludes data from the EISB Pilot Test period (July 2003 – April 2004)+ cis-DCE concentrations shown for MW-8 (pilot test well)

  • 23

    1,1,1-TCA Concentrations (ppb)Historic Range* April 2017 Results

    Source Area Monitoring WellsMW-8 (shallow overburden) 25 – 1,000 0.72 JMW-8B (shallow overburden) < 1 - 24 714MW-8C (shallow overburden) 1.2 - 190 0.78 JMW-8D (shallow overburden) 2.5 - 710 < 0.22MW-20 (intermediate till) 2.7 – 1,100 25.6MW-18 (deep till) 0.7 – 5.9 0.42 JBarrier Segment “B” Monitoring WellMW-21 (deep till) < 13 - 100 < 0.22Barrier Segment “A” Monitoring WellMW-22 (deep till) 3.6 - 520 < 0.22

    Notes:NJ GWQS for TCA = 1 ppbJ = estimated value*Excludes data from the EISB Pilot Test period (July 2003 – April 2004)

  • Sentinel Monitoring Well

    24

  • 25

    Baseline TCE = 4,980 ppb

    April 2017 TCE = 2,670 ppb

    EVO InjectionsComplete

    Bioaugmentation

    5/1/20145/31/20146/30/20147/30/20148/29/20149/28/201410/28/201411/27/201412/27/20141/26/20152/25/20153/27/20154/26/20155/26/20156/25/20157/25/20158/24/20159/23/201510/23/201511/22/201512/22/20151/21/20162/20/20163/21/20164/20/20165/20/20166/19/20167/19/20168/18/20169/17/201610/17/201611/16/201612/16/20161/15/20172/14/20173/16/20174/15/2017

    0

    150

    0

    5

    10

    15

    20

    25

    30

    35

    40

    45

    50

    May

    -14

    May

    -14

    Jun-

    14Ju

    l-14

    Aug-

    14Se

    p-14

    Oct

    -14

    Nov

    -14

    Dec-

    14Ja

    n-15

    Feb-

    15M

    ar-1

    5Ap

    r-15

    May

    -15

    Jun-

    15Ju

    l-15

    Aug-

    15Se

    p-15

    Oct

    -15

    Nov

    -15

    Dec-

    15Ja

    n-16

    Feb-

    16M

    ar-1

    6Ap

    r-16

    May

    -16

    Jun-

    16Ju

    l-16

    Aug-

    16Se

    p-16

    Oct

    -16

    Nov

    -16

    Dec-

    16Ja

    n-17

    Feb-

    17M

    ar-1

    7Ap

    r-17

    Tota

    l VFA

    Con

    cent

    ratio

    n (m

    g/L)

    VOC

    Conc

    entr

    atio

    n (µ

    M)

    MW-29: Sentinel A - Deep Till Zone

    PCE TCE cDCE VC Ethene + Ethane Total VFA's

  • 26

    Post-Bioaugmentation

    Sample collected for CENSUS-DNA analysis by Microbial Insights, Inc.

    June 2015 Jan 2016 April 2017MW-8C 1.90 x 109 N/A N/A

    MW-20 2.13 x 107 N/A 3.46 x 106

    MW-21 2.84 x 104 3.28 x 108 N/AMW-22 7.58 x 108 N/A N/A

    MW-29 4.80 x 103 N/A 1.90 x 103

    MW-25BR N/A 2.20 x 108 N/A

    Note:Literature established 1 x 107 cells/L as a threshold for generally useful rates of dechlorination (Lu et. Al., 2006)

    CENSUS-DNA:Dehalococcoides (Dhc) Results (cells/L)

    Sheet1

    Revlon EISB GW Performance Monitoring

    CENSUS-DNA Dhc Results

    Well IDMW-8CMW-20MW-21MW-22MW-29MW-25BR

    EISB ZoneShallow Source AreaIntermediate Source AreaIntermediate Source AreaGrove BarrierGrove BarrierLyons BarrierSentinel ASentinel ASentinel B

    Sample Date6/10/156/10/154/20/176/10/151/16/166/10/156/10/154/20/171/16/16

    Dehalococcoides (Dhc) (cells/L)1.90E+092.13E+073.46E+062.84E+043.28E+087.58E+084.80E+031.90E+032.20E+08

    Notes:

    Cell density of TSI-DC culture is approximately 1.00E+11 cells/L

    Research by EPA (Lu et. al., 2006 ) established 1E+07 Dhc cells/L as a threshold for generally useful rates of dechlorination. Also, the Microbial Insights database revealed that ethene production is observed in nearly 80% of samples where Dhc concentrations are at least 1E+04 cells/mL (1E+07 cells/L), which is in good agreement with the threshold Dhc concentration proposed by Lu et. al. (2006).

    Revlon Implements Division IIrvington, New JerseyDRAFT - PRIVILEGED && CONFIDENTIAL

    O'Brien && Gere Engineers, Inc.February 2016

    formatted

    Revlon EISB GW Performance Monitoring

    CENSUS-DNA Dhc Results

    Well IDMW-8CMW-20MW-21MW-22MW-29MW-25BR

    EISB ZoneShallow Source AreaIntermediate Source AreaIntermediate Source AreaGrove BarrierGrove BarrierLyons BarrierSentinel ASentinel ASentinel B

    Sample Date6/10/156/10/154/20/176/10/151/16/166/10/156/10/154/20/171/16/16

    Dehalococcoides (Dhc) (cells/L)1.90E+092.13E+073.46E+062.84E+043.28E+087.58E+084.80E+031.90E+032.20E+08

    Notes:

    Cell density of TSI-DC culture is approximately 1.00E+11 cells/L

    Research by EPA (Lu et. al., 2006 ) established 1E+07 Dhc cells/L as a threshold for generally useful rates of dechlorination. Also, the Microbial Insights database revealed that ethene production is observed in nearly 80% of samples where Dhc concentrations are at least 1E+04 cells/mL (1E+07 cells/L), which is in good agreement with the threshold Dhc concentration proposed by Lu et. al. (2006).

    CENSUS-DNA:

    Dehalococcoides (Dhc) Results (cells/L)

    June 2015Jan 2016April 2017

    MW-8C1.90 x 109N/AN/A

    MW-202.13 x 107N/A3.46 x 106

    MW-212.84 x 1043.28 x 108N/A

    MW-227.58 x 108N/AN/A

    MW-294.80 x 103N/A1.90 x 103

    MW-25BRN/A2.20 x 108N/A

    Note:

    Literature established 1 x 107 cells/L as a threshold for generally useful rates of dechlorination (Lu et. Al., 2006)

    Revlon Implements Division IIrvington, New JerseyDRAFT - PRIVILEGED && CONFIDENTIAL

    O'Brien && Gere Engineers, Inc.February 2016

  • 27

    January 2012TCE = 850 ppb

    April 2017 TCE = 41.7 ppb

    EVOInjectionsComplete

    Bioaugmentation

    0

    100

    200

    300

    400

    500

    600

    700

    0

    2

    4

    6

    8

    10

    12

    Jan-

    12

    Mar

    -12

    Jun-

    12

    Sep-

    12

    Dec-

    12

    Mar

    -13

    Jun-

    13

    Sep-

    13

    Dec-

    13

    Mar

    -14

    Jun-

    14

    Sep-

    14

    Dec-

    14

    Mar

    -15

    Jun-

    15

    Sep-

    15

    Dec-

    15

    Mar

    -16

    Jun-

    16

    Sep-

    16

    Dec-

    16

    Mar

    -17

    Jun-

    17

    Benz

    ene

    Conc

    entr

    atio

    n (μ

    g/L)

    VOC

    Conc

    entr

    atio

    n (µ

    M)

    MW-25BR: Sentinel B - Bedrock ZoneChlorinated Ethenes / Ethene + Ethane Concentrations

    vs. Benzene Concentration over Time

    Ethene + Ethane not measured

    Baseline GW Sampling Event

    (Pre- Full-Scale EISB)

  • Methane production is expected as a result of EISB

    28

    MW-8C MW-20 MW-21Shallow/Source Int/Source Deep/Biobarrier

    5/28/2014 8.4 2.9 23011/4/2014 12 19 351/5/2015 280 20 3,3006/10/2015 1,900 120 13,0008/26/2015 3,300 440 27,0001/14/2016 9,700 -- 26,0009/26/2016 11,000 11,000 27,0004/21/2017 15,000 6,300 17,000

    Dissolved Methane in GW Results (ug/L)

    Multigas meter used to check: Interior of Site building Basement spaces across street Nearby drainage inlets Shallow monitoring wells

    downgradientNo evidence of methane accumulation was found

    Injection wells fitted with vented well caps to prevent methane gas buildup

    Dissolved Methane in GW

    Dissolved Methane in GW Results (ug/L)MW-8MW-8BMW-8CMW-8DMW-18MW-20MW-21MW-22

    Shallow/SourceShallow/SourceShallow/SourceShallow/SourceDeep/SourceInt/SourceDeep/GroveDeep/Lyons

    5/28/14--1008.41.42502.92303400

    11/4/142003312--23019352,900

    1/5/15320270280--220203,3003,600

    4/22/151,7001,500----260--16,0009,100

    6/10/155,2007,8001,900----12013,00018,000

    8/26/15--8,1003,30025,000--44027,00023,000

    1/14/167,10010,0009,70013,000----26,00028,000

    4/21/174,50010,00015,00019,000230630017,00022,000

    Dissolved Methane in GW Results (ug/L)MW-14MW-16MW-19MW-24MW-25MW-29C-1C-8

    Shallow/Sent AInt/Sent ADeep/Sent ADeep/Sent ADeep/Sent ADeep/Sent ADeep/Sent ADeep/Sent A

    5/28/140.38182100.582.998--52

    1/6/15< 0.10132400.496.4140--50

    6/10/15< 0.50123300.653.31104227

    Dissolved Methane in GW Results (ug/L)MW-17MW-28MW-19BRMW-24BRMW-25BR

    Int/Sent BDeep/Sent BDeep/Sent BDeep/Sent BDeep/Sent B

    5/28/1412016013036220

    6/9/1513013012062200

    Notes:

    * - Soil gas monitoring is suggested for groundwater with methane concentrations > 10 mg/L (10,000 ug/L)

    Dissolved Methane in GW Results (ug/L)

    MW-8CMW-20MW-21

    Shallow/SourceInt/SourceDeep/Biobarrier

    5/28/148.42.9230

    11/4/14121935

    1/5/15280203,300

    6/10/151,90012013,000

    8/26/153,30044027,000

    1/14/169,700--26,000

    9/26/1611,00011,00027,000

    4/21/1715,0006,30017,000

    Methane Gas Monitoring - MWs

    Methane Gas Detected (%LEL)5/5/156/10/158/26/15

    EISB Zone Wells

    MW-8--08.3

    MW-8B10014.63.7

    MW-8C28.120.614.1

    MW-8D12.910.95.3

    MW-15--06.1

    MW-18000

    MW-20000.3

    MW-2116.011.03.1

    MW-2218.016.44.8

    Sentinel A Wells

    MW-14--00

    MW-16--00

    MW-19--00

    MW-24--0--

    MW-25--0--

    MW-29--00.1

    C-1--00

    C-8--00

    Sentinel B Wells

    MW-17--00

    MW-28--00

    MW-19BR--00

    MW-24BR--0--

    MW-25BR--0--

    Other

    MW-6--00

    MW-10--00

    MW-23--03.1

    Notes:

    The explosive range of methane is 5 - 15% methane in air by volume

    Methane gas meter measurements presented in percentage of the lower explosive limit (LEL - 5% methane by volume in air)

    Methane Gas Monitoring - IWs

    Methane Gas Detected (%LEL)5/5/158/26/15

    EISB Zone Wells

    IW-5019.6

    IW-605.2

    S-1022.3

    S-3020.5

    S-503.6

    G-300.9

    G-6024.4

    G-700.2

    G-804.8

    G-9031.8

    L-20100

    L-5045.6

    L-6015.2

    L-8023.6

    L-9039.2

    Notes:

    The explosive range of methane is 5 - 15% methane in air by volume

    Methane gas meter measurements presented in percentage of the lower explosive limit (LEL - 5% methane by volume in air)

    Sheet1

  • Performance Monitoring Conclusions

    29

    EVO + bioaugmentation injections were successful in establishing conditions for EISB in the source area and biobarrier treatment zones

    VFA depletion is not an immediate concern along the biobarriers and majority of source area

    Dhc population is thriving in EISB treatment zones, as well as in the downgradient bedrock zone

    Some of the VFAs are being utilized by methanogens, resulting in high levels of dissolved methane in groundwater

  • OBG PRESENTS:OBG | THERE’S A WAY

    [email protected]

    http://www.obg.com/https://www.facebook.com/obriengerehttps://plus.google.com/u/0/102830418912731359819/postshttps://instagram.com/obrien_gere/https://www.linkedin.com/company/o'brien-&-gerehttps://twitter.com/obrien_gerehttps://www.youtube.com/user/obrienandgere

    EVO / Bioaugmentation for Treatment of Trichloroethene by Biobarrier and Source Injection Approach�Christine Fogas (OBG), Michael Kozar, P.G. (OBG), Bella Bakrania (OBG), and Eric Schleicher, P.G. (OBG)��Fourth International Symposium on Bioremediation and Sustainable Environmental Technologies�May 22-25, 2017, Miami, FLEmulsified Vegetable Oil (EVO) and Bioaugmentation for Treatment of Trichloroethene (TCE) by “Biobarrier” and Source Injection ApproachBackgroundSite SettingSlide Number 5Slide Number 6Enhanced In Situ Bioremediation (EISB) �Proof of ConceptSlide Number 8Slide Number 9ImplementationOverview / �ChronologyInjection Well�InstallationEVO InjectionsSlide Number 14BioaugmentationPerformance MonitoringEVO is fermented to release volatile fatty acids (VFAs), which act as a carbon source for Dhc and other microbesEISB �Monitoring WellsSlide Number 19Slide Number 20Slide Number 21Slide Number 22Slide Number 23Sentinel Monitoring �WellSlide Number 25Slide Number 26Slide Number 27Methane production is expected as a result of EISBPerformance Monitoring ConclusionsQuestions?